BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30471778)

  • 1. PYY(3-36) and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice.
    Kjaergaard M; Salinas CBG; Rehfeld JF; Secher A; Raun K; Wulff BS
    Neuropeptides; 2019 Feb; 73():89-95. PubMed ID: 30471778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice.
    Talsania T; Anini Y; Siu S; Drucker DJ; Brubaker PL
    Endocrinology; 2005 Sep; 146(9):3748-56. PubMed ID: 15932924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
    Riediger T; Bothe C; Becskei C; Lutz TA
    Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYY(3-36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of rats.
    Blevins JE; Chelikani PK; Haver AC; Reidelberger RD
    Peptides; 2008 Jan; 29(1):112-9. PubMed ID: 18082288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut hormone PYY(3-36) physiologically inhibits food intake.
    Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; Low MJ; Ghatei MA; Cone RD; Bloom SR
    Nature; 2002 Aug; 418(6898):650-4. PubMed ID: 12167864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide YY 3-36 and pancreatic polypeptide differentially regulate hypothalamic neuronal activity in mice in vivo as measured by manganese-enhanced magnetic resonance imaging.
    Hankir MK; Parkinson JR; Minnion JS; Addison ML; Bloom SR; Bell JD
    J Neuroendocrinol; 2011 Apr; 23(4):371-80. PubMed ID: 21251093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PYY3-36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in mice.
    Shi YC; Lin Z; Lau J; Zhang H; Yagi M; Kanzler I; Sainsbury A; Herzog H; Lin S
    Obesity (Silver Spring); 2013 Dec; 21(12):E669-78. PubMed ID: 23804428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala.
    Parker JA; McCullough KA; Field BC; Minnion JS; Martin NM; Ghatei MA; Bloom SR
    Int J Obes (Lond); 2013 Oct; 37(10):1391-8. PubMed ID: 23337772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro.
    Dalvi PS; Nazarians-Armavil A; Purser MJ; Belsham DD
    Endocrinology; 2012 May; 153(5):2208-22. PubMed ID: 22334721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of central nesfatin-1 neurons on oxytocin-induced feeding suppression in rats.
    Saito R; Sonoda S; Ueno H; Motojima Y; Yoshimura M; Maruyama T; Hashimoto H; Tanaka K; Yamamoto Y; Kusuhara K; Ueta Y
    Neurosci Lett; 2017 Aug; 655():54-60. PubMed ID: 28684238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism.
    Halatchev IG; Ellacott KL; Fan W; Cone RD
    Endocrinology; 2004 Jun; 145(6):2585-90. PubMed ID: 15016721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of apolipoprotein A-IV and cholecystokinin1 receptors in exogenous peptide YY3 36-induced stimulation of intestinal feedback.
    Whited KL; Tso P; Raybould HE
    Endocrinology; 2007 Oct; 148(10):4695-703. PubMed ID: 17641001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of albumin-conjugated PYY on food intake: the respective roles of the circumventricular organs and vagus nerve.
    Baraboi ED; Michel C; Smith P; Thibaudeau K; Ferguson AV; Richard D
    Eur J Neurosci; 2010 Sep; 32(5):826-39. PubMed ID: 20646064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fourth ventricular CART peptide induces c-fos in the area postrema and nucleus of the solitary tract via a CRF-receptor dependent mechanism.
    Smedh U; Scott KA; Moran TH
    Neurosci Lett; 2015 Nov; 609():124-8. PubMed ID: 26475505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
    Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
    Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary delivery of peptide YY for food intake suppression and reduced body weight gain in rats.
    Nadkarni PP; Costanzo RM; Sakagami M
    Diabetes Obes Metab; 2011 May; 13(5):408-17. PubMed ID: 21226821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
    Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
    Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli.
    Züger D; Forster K; Lutz TA; Riediger T
    Physiol Behav; 2013 Mar; 112-113():61-9. PubMed ID: 23438370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
    Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.